share_log
Reuters ·  May 2 07:30
Palatin Technologies Inc: Phase 2 Clinical Study Expected to Begin in Mid-Calendar Year 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment